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Purpose: To develop and validate a deep learning model for the automatic segmentation of geographic
atrophy (GA) using color fundus images (CFIs) and its application to study the growth rate of GA.
Design: Prospective, multicenter, natural history study with up to 15 years of follow-up.
Participants: Four hundred nine CFIs of 238 eyes with GA from the Rotterdam Study (RS) and Blue Mountain
Eye Study (BMES) for model development, and 3589 CFIs of 376 eyes from the Age-Related Eye Disease Study
(AREDS) for analysis of GA growth rate.
Methods: A deep learning model based on an ensemble of encoderedecoder architectures was imple-
mented and optimized for the segmentation of GA in CFIs. Four experienced graders delineated, in consensus,
GA in CFIs from the RS and BMES. These manual delineations were used to evaluate the segmentation model
using 5-fold cross-validation. The model was applied further to CFIs from the AREDS to study the growth rate of
GA. Linear regression analysis was used to study associations between structural biomarkers at baseline and the
GA growth rate. A general estimate of the progression of GA area over time was made by combining growth rates
of all eyes with GA from the AREDS set.
Main Outcome Measures: Automatically segmented GA and GA growth rate.
Results: The model obtained an average Dice coefﬁcient of 0.720.26 on the BMES and RS set while
comparing the automatically segmented GA area with the graders’ manual delineations. An intraclass correlation
coefﬁcient of 0.83 was reached between the automatically estimated GA area and the graders’ consensus
measures. Nine automatically calculated structural biomarkers (area, ﬁlled area, convex area, convex solidity,
eccentricity, roundness, foveal involvement, perimeter, and circularity) were signiﬁcantly associated with growth
rate. Combining all growth rates indicated that GA area grows quadratically up to an area of approximately 12
mm2, after which growth rate stabilizes or decreases.
Conclusions: The deep learning model allowed for fully automatic and robust segmentation of GA on CFIs.
These segmentations can be used to extract structural characteristics of GA that predict its growth
rate. Ophthalmology 2020;-:1e11 ª 2020 by the American Academy of Ophthalmology. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Supplemental material available at www.aaojournal.org.Geographic atrophy (GA) occurs in the advanced stage of
age-related macular degeneration (AMD). It is characterized
by progressive atrophy of the retinal pigment epithelium,
overlying photoreceptors, and underlying choriocapillaris.1
Areas of GA often initially appear extrafoveal, which may
result in their causing difﬁculties in reading or dim-light
vision.2 Over time, the atrophic area may grow, and when
it reaches the fovea, visual acuity is severely diminished.
Prevalence of GA increases exponentially with age3 and is
highest in people of European ancestry.4 The number of
people affected by GA is expected to increase further in
the near future because of the aging population.5ª 2020 by the American Academy of Ophthalmology
This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by Elsevier Inc.Currently, no approved treatment exists to prevent pro-
gression of GA.6,7 However, clinical trials of several
potential therapies are underway.8 For evaluation of these
trials, reliable anatomic end points are required, because
visual acuity alone provides insufﬁcient insight in the
severity of the disease.9 Growth rate of the atrophic area
has been suggested as an important indicator of disease
progression.9e11 However, the speed at which GA pro-
gresses varies greatly between patients.12e14 Therefore,
understanding the patterns associated with progression and
the variability between patients is important for the design
and interpretation of clinical trials.1https://doi.org/10.1016/j.ophtha.2020.02.009
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area is required. However, because manual delineation can
be challenging and time consuming,15,16 automatic
segmentation could provide a scalable and reproducible
alternative. Deep learning has emerged as a powerful
technique for the automatic analysis of medical images.17
Deep learning models require labeled examples (training
data) to tune their internal parameters. The model then
learns to extract features that are important for the
segmentation task without further need for explicit domain
knowledge from experts. It has been successfully applied
to color fundus images (CFIs) for classiﬁcation of severity
stages in AMD18,19 and diabetic retinopathy20e22 and
recently also for the detection of GA.23 Although manually
labeled examples are still required for training and
validation, the model thereafter can be applied to large
data sets, opening up new possibilities for studies and
possibly reducing the overall effort that is required from
experienced graders.
These automatic methods also have the potential to
extract structural characteristics of GA efﬁciently and
accurately, as seen in imaging that has been demonstrated to
correlate with growth rate. For example, multifocal lesions
grow faster than unifocal lesions,24 and extrafoveal lesions
grow faster than foveal lesions.13 Circular lesions have
been demonstrated to grow at a slower rate than more
irregularly shaped lesions.25 Baseline lesion area has been
consistently associated with future growth, with larger
lesions growing faster than smaller lesions.11,13,26,27
However, applying a square root transformation to the
lesion size may remove this dependency.16,28 Therefore, it
has been hypothesized that lesions with approximate
circular shape grow at a constant radial speed, thus
leading to a quadratic growth of the area.16,29
Various imaging methods have been used to assess GA.
Color fundus imaging has been used most widely histori-
cally, particularly in large epidemiologic studies.12 More
recently, fundus autoﬂuorescence (FAF) and OCT have
also become popular for the study of GA and GA
progression.13,16,27 Several lesion characteristics visible
with those methods can be linked to progression of GA.
For example, banded or diffuse perilesional patterns on
FAF and structural abnormalities at the junctional zone on
OCT have been associated with faster GA
progression.13,27,30 Although GA may be detected earlier
on FAF images than CFIs,31 good agreement on
quantiﬁcation of GA area on CFIs between 2 independent
reading centers has been demonstrated,11 and progression
rates assessed from both FAF images and CFIs are highly
correlated.13,31 Color fundus imaging has the advantage
that it is widely available, often over longer periods,
making it suitable for the study of long-term progression
of GA.
Previous work on automatic methods for segmentation of
GA focuses mainly on OCT32e34 or FAF.35 Feeny et al36
proposed a method based on a random forest classiﬁer in
color fundus imaging. In contrast, herein we present a
model that is based on deep learning.
The purpose of this study is twofold: (1) to develop and
validate a fully automatic model for segmentation of GA on2CFIs and (2) to demonstrate its usefulness in a longitudinal
setting for the study of GA progression. The performance of
the developed model was compared against the work of 4
graders on a challenging dataset to evaluate its robustness.
Next, the automatically segmented GA areas provided
measures of structural characteristics related to lesion size,
location, and morphologic features. We investigated the
associations between those structural characteristics at
baseline and the subsequent growth rate of GA. Finally, we
combined GA growth rates across patients to obtain an es-
timate of average progression of GA area over time.Methods
Data
Data for development and evaluation of the deep learning model
for GA segmentation were collected from the Blue Mountains Eye
Study (BMES)37 and the Rotterdam Study (RS) cohorts I, II, and
III.38 The developed model was applied to CFIs from the Age-
Related Eye Disease Study (AREDS)11 for the assessment of GA
growth rate.
The BMES is a population study from the Blue Mountains
region in Australia that started between 1992 and 1994 and
included 3654 participants 49 years of age or older. For the ﬁrst 3
visits, 30 macula-centered (ﬁeld 2) CFIs were obtained with a
Zeiss fundus camera (Carl Zeiss AG, Oberkochen, Germany). For
the fourth visit, 40 macula-centered digital CFIs were obtained
with a Canon CF-60 DSi with DS Mark II body (Canon, Tokyo,
Japan). The BMES was approved by the University of Sydney and
the Sydney West Area Health Service Human Research Ethics
Committees.
The RS is a population study from a suburb in Rotterdam, The
Netherlands. The RS cohort I started in 1990 and included 7983
participants 55 years of age or older. Cohort II started in 2000 and
included 3011 participants 55 years of age or older. Cohort III
started in 2006 and included 3932 participants 45 years of age or
older. The CFIs for the ﬁrst examinations were obtained with a
Topcon TRV-50VT (Topcon Optical Company, Tokyo, Japan),
and those from the last 2 examinations were obtained with a
Topcon TRC 50EX and a Sony DXC-950P (Sony Electronics Inc.,
New York, NY) digital camera. All CFIs were 35 and macula
centered (ﬁeld 2). The RS was approved by the Medical Ethics
Committee of the Erasmus Medical Center and by the Netherlands
Ministry of Health, Welfare and Sport.
The AREDS is a long-term, multicenter, prospective study of
the clinical course of AMD and cataract. Starting between 1992
and 1998, 11 clinics in the United States enrolled 4757 participants
between 55 and 80 years of age. Stereoscopic CFIs (30 macula
centered) were acquired with a Zeiss FF-series camera (Carl Zeiss
AG). The AREDS was approved by an independent institutional
review board at each clinical center.
The follow-up interval for RS and BMES was 5 years. The
AREDS had follow-ups at 6-month intervals, although the typical
interval between available CFIs was 1 year. The BMES, RS, and
AREDS all adhered to the tenets of the Declaration of Helsinki,
and all participants provided informed consent.
A total of 504 CFIs of patients diagnosed with AMD and signs
of GA were included from the BMES and RS sets. Twenty-six
images with mixed signs of AMD (neovascularization, bleedings,
scars) were excluded to disambiguate overlapping areas. Further-
more, no GA was delineated in 43 images because it was either not
present or ungradable, and 26 images were excluded because of
poor image quality. The remaining 409 images were included for
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set contained 87 images from the BMES (26 participants, 43 eyes)
and 322 images from the RS (149 participants, 195 eyes). The 409
images represent 315 unique visits (some visits had 2 CFIs
available).
Images for the study of GA progression were selected from the
AREDS set, following the grading available from the database of
genotype and phenotype 2014 table. Inclusion criteria were pres-
ence of GA or central GA and at least 2 years of follow-up. Images
with neovascular disease co-occurring with GA were excluded. A
total of 3589 images of 376 eyes were included. Most of these
images were stereoscopic, so this accounted for 1826 unique ac-
quisitions (eye-visit). Pixel-to-millimeter conversion was ﬁxed for
all images, based on the average distance between the fovea and
center of the optic disc measured in a subset of the images. This
distance was assumed to be 4.5 mm.39
Delineations of GA area were made by 4 graders (3 of them
with more than 20 years of experience), using an in-house created
software platform for manual annotations (https://www.a-eye-
research.nl/software/ophthalmology_workstation/).40 For the RS,
additional multimodal imaging (infrared, FAF, OCT, or a
combination thereof) was available for some of the visits, and
the platform allowed images of the same eye (both multimodal
and longitudinal) to be aligned manually by identifying
corresponding landmarks. The graders could view images of the
same eye simultaneously using a synchronized cursor on
multiple screens. Geographic atrophy was identiﬁed as the
absence of the retinal pigment epithelium and increased visibility
of the choriocapillaris on CFIs. Additional evidence from other
methods was used whenever available. Areas of macular and
peripapillary atrophy were delineated as separate classes, but for
this study, only macular GA was used.
Each grader annotated the entire BMES set, whereas the RS set
was divided in such a way that each grader annotated approxi-
mately half of the entire set and every image was graded by at least
2 graders. Finally, a consensus grading was made for all images in
both sets. During the consensus grading, all graders decided
together which of the individual gradings was most accurate and
updated this grading, if necessary, until consensus was reached. If
2 CFIs of the same visit were present, both were included for
model development, and the delineated GA area was propagated
from one image to the other by using the afﬁne transformation
calculated from the manual landmarks. For evaluation, only the
CFI that was used to make the consensus grading was used.
Additionally, for external validation of the model, we randomly
selected 100 CFIs from 100 participants in the subset of AREDS
images that contain GA (including 32 CFIs with co-occurring
neovascular lesions). A single grader delineated the GA area in
all of these images, whereas an additional 2 graders delineated GA
in 50 of the 100 selected CFIs.
Deep Learning Model
The proposed deep learning model for GA segmentation consisted
of an ensemble of several models, each trained with partly over-
lapping training sets. The network architecture (the topology of
connections between internal parameters of the deep learning
model) for each model consisted of a deep encoderedecoder
structure with residual blocks and shortcut connections, similar
to that of De Fauw et al,41 but adapted to work with CFIs. This
architecture, and its variations, can be characterized by a
contracting path in which the high-resolution input image is con-
verted to a low-resolution abstract representation, followed by an
expanding path in which the original resolution is reconstructed.
The contracting and expanding path are connected by shortcut
connections. This approach has been shown to be very effective forsemantic segmentation in medical imaging for which large
contextual information is required.17,42
Input to each model was both the original color (RGB) image
and a contrast-enhanced version of the same image, both resampled
to 512512 pixels. The contrast-enhanced image was obtained by
subtracting a blurred image from the original image.43 The input
was transformed through the many layers of artiﬁcial neurons in
the contracting and expanding path and ultimately yielded a new
image in which the value of every pixel represented a likelihood
of being part of an area of GA. A schematic overview of the
model can be found in Figure 1. More details about the model
and the training procedure used for this study can be found in
the Appendix (available at www.aaojournal.org).
Geographic Atrophy Segmentation
For the development and validation of the model, we applied a 5-
fold cross-validation scheme. Data from the BMES and RS were
merged into 1 dataset and split randomly at the patient level into 5
approximately equal folds. In a rotating scheme, 4 folds were used
for model training and validation (development set), whereas the
remaining fold was used for performance evaluation (test set).
Furthermore, 4 separate models were created within each devel-
opment set. Each model used 3 folds for tuning of the internal
parameters (training) and 1 for validation. An ensemble of these 4
models was then evaluated on the respective test set. The output of
the ensemble model was obtained by taking the average output of
the individual models for every pixel, after correcting for differ-
ences in sensitivity between models. This procedure is explained in
more detail in the Appendix (available at www.aaojournal.org).
Ultimately, an ensemble of the 20 obtained models (4 models
developed for each of the 5 rounds) constituted the ﬁnal model.
Performance of this model was validated on the selection of 100
CFIs from the AREDS set.
The performance of the model and the agreement between
graders were assessed using the Dice coefﬁcient, which is deﬁned
as 2 times the intersection of 2 areas divided by the sum of the
individual areas. Hence, a value of 0 represents disjoint areas (no
overlap), whereas a value of 1 represents perfect agreement. Dice
coefﬁcients were calculated between graders to assess the inter-
observer agreement, whereas the areas delineated in the consensus
grading were used as reference for the model. Note that the
consensus grading was not independent of the individual gradings
and therefore could not be used as a reference to estimate graders’
performances. Furthermore, the intraclass correlation coefﬁcient of
the GA area and the square root of the GA area were used to
measure agreement between graders and the model.
Geographic Atrophy Growth Rate
The ﬁnal deep learning model (the ensemble of 20 models) was
applied to CFIs from AREDS for the analysis of GA progression. It
is well documented that GA area increases faster for larger lesions.
To remove the dependency of baseline lesion size on growth rate,
many researchers apply a square root transformation to the GA
area.28 Similarly, we calculated the square root annual growth in
millimeters per year for each eye to assess progression in the
AREDS set.39 This value was obtained from the slope of a linear
regression through the square root of the GA area for a selected
set of time points. The selected set consisted of all available
CFIs within a window of 2 years for which the number of
available CFIs was highest for the respective eye. The window
was limited at 2 years because growth rate and lesion
characteristics may change over time.25 We calculated the
correlation of square root annual growth rate between fellow
eyes and compared the growth rate between groups using an3
Figure 1. Schematic overview of the model. On the left, the preprocessed input: a 512512 color image (RGB) and a contrast-enhanced (CE) version. In
the middle, the model, with the downsampling path (orange arrows), upsampling path (green arrows), and shortcut connections (gray arrows). The ensemble
model combines multiple outputs into a single binary image. The geographic atrophy (GA) area in the chosen example is intentionally ambiguous to
highlight how the ensemble handles differences in predicted GA between the individual models.
Table 1. Dice Coefﬁcients between Model and Consensus
Grading and between Individual Graders
No. Dice coefﬁcient
Model e consensus 315 0.720.26
Grader 1 e grader 2 146 0.800.27
Grader 1 e grader 3 138 0.780.27
Grader 1 e grader 4 90 0.720.26
Grader 2 e grader 3 91 0.820.21
Grader 2 e grader 4 134 0.780.22
Grader 3 e grader 4 130 0.780.19
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multifocal cases, and foveal versus extrafoveal cases.
To identify structural characteristics or features that may be
predictive for growth rate, we built a linear model based on features
that were extracted from the segmented GA area at baseline (the
ﬁrst image within the selected window). Candidate features were
area, perimeter, convex area, ﬁlled area, convex solidity (area
divided by convex area), ﬁlled area (area divided by ﬁlled area),
number of lesions, eccentricity, circularity, roundness, and foveal
involvement. Details on how these features were calculated can be
found in the Appendix (available at www.aaojournal.org).
Associations between individual features and square root annual
growth rate were calculated using univariate linear regression.
Because the features were not independent, a multivariate linear
model was created to investigate further which features best
explain variation in square root annual growth rate. The
multivariate model was built using forward selection by
iteratively adding the feature that yielded the highest increase in
adjusted R2 value, until it increased no further. When
stereoscopic images were available, lesion characteristics were
represented by the mean of the 2 calculated values. To obtain a
more homogeneous set for the prediction model, we discarded
images in which the relative difference in GA area between the
left and right stereoscopic image was more than 50% and
included only eyes with at least 2 years of follow-up images.
Finally, we combined all estimates of GA growth in a single
ﬁgure. Geographic atrophy growth in square millimeters per year
(not square root transformed) was estimated as a function of GA
area, again using a linear regression for each eye through the GA
area in a window of 2 years. This resulted in an estimate of GA
growth (the slope of the regression), bounded by a minimum and
maximum GA area. The estimated general GA growth for a given
GA area was then represented by the mean of all growth estimates
for which this GA area fell within the respective area bounds.
Conﬁdence intervals were estimated using bootstrapping.4Results
Geographic Atrophy Segmentation
The deep learning model reached a Dice coefﬁcient of
0.720.26 (n ¼ 315), measured in cross-validation in the
BMES and RS data sets, where each test fold was evaluated
by the ensemble of 4 models. Dice coefﬁcients between 2
independent graders ranged from 0.720.26 to 0.820.21
(0.780.24 on average). See Table 1 for more details. The
intraclass correlation coefﬁcient between the model and
the consensus was 0.83 for GA area and 0.84 for the
square root of the GA area. Consistency in those values is
visualized further in Figure 2 using Bland-Altman plots.
The mean value of the differences between consensus and
model did not differ signiﬁcantly from 0 on the basis of a 1-
sample t test for either GA area (P ¼ 0.82) or square root
GA area (P ¼ 0.22). Examples of manually and automati-
cally segmented GA areas can be found in Figure 3.
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0.660.27 (n ¼ 50) for the model, compared with
0.730.24 (grader 1) and 0.730.27 (grader 2). The intra-
class correlation coefﬁcient between the model and refer-
ence grader was 0.77 for GA area and 0.80 for the square
root of the GA area (n ¼ 100). The mean value of the dif-
ferences between reference and model did not differ
signiﬁcantly from 0 on the basis of a 1-sample t test for
either GA area (P ¼ 0.59) or square root GA area (P ¼
0.54). Examples of automatic segmentation results on the
AREDS set can be found in Figure S1 (available at
www.aaojournal.org).
Geographic Atrophy Growth Rate
After excluding visits at which the difference between left
and right stereoscopic images in the automatically
segmented area was more than 50%, 335 of the 376 eyes in
the AREDS with at least 2 years of follow-up remained.
Square root annual growth of GA for those eyes was
0.250.40 mm/year. This value was signiﬁcantly higher for
eyes with small (<5 mm2) baseline GA area (0.310.34
mm/year; n ¼ 194) compared with eyes with large (5
mm2) baseline GA area (0.160.46; n ¼ 141 mm/year;
P < 0.001). Table 2 shows differences in growth rate
between groups. We observed that multifocal and
extrafoveal lesions grow faster than unifocal or foveal
lesions. Patients with bilateral GA showed faster
progression than patients with unilateral GA, although this
was not signiﬁcant in our analysis (P ¼ 0.58). Growth
rates between fellow eyes were correlated (r ¼ 0.58;
P < 0.001). Figure 4 highlights progression of GA for
selected individual eyes.
Correlations between baseline lesion characteristic and
square root annual growth are summarized in Table 3. Nine
of 11 features were signiﬁcantly correlated with GA growth
rate (after Bonferroni correction). Correlations for the subset
with baseline lesions size smaller than 12 mm2 are analyzed
in Table 4. Features included in the multivariate model were
area, circularity, convex area, eccentricity, fovealFigure 2. Bland-Altman plot showing (A) geographic atrophy (GA) area and (
root area of the consensus grading minus the automatic segmentation. SD ¼ stinvolvement, and number of lesions. The coefﬁcient of
determination of this model was 0.18. A visualization that
summarizes growth over time for all eyes with GA in the
AREDS set can be found in Figure 5. The red dashed line
in these graphs represent a quadratic model that best ﬁtted
the data for GA area of less than 12 mm2.Discussion
A deep learning model for segmentation of GA on CFIs was
developed and evaluated. We demonstrated how the auto-
matically obtained segmentations of the model can be used
to study the growth rate of GA on an independent set and
reproduced several previously reported associations with
growth rate. The model can also be applied to datasets for
which GA measurements are not yet available, providing a
fast alternative to manual delineation.
The performance of the deep learning model in terms of
Dice coefﬁcient on the BMES and RS set approached that of
human experts. The model was able to identify GA even
when image quality or contrast were relatively poor, as
demonstrated in Figure 3. Nevertheless, some failure cases
remained, which was the main reason for the lower
average Dice coefﬁcient. We suspect that more training
data may solve this issue, because each of the models
used only 60% of the data (approximately 245 images) for
training, which may not be enough given the inherent
difﬁculty of the problem and the variability in the data.
For application to the AREDS set, this problem was
circumvented partly by using an ensemble model, which
indirectly made use of all training data.
Generalization ability of the model to the AREDS set
was assessed on a subset of 50 CFIs. We separately
analyzed the performance of the model for cases of pure GA
and mixed late AMD, with co-occurring neovascular lesions
(Table 5). Performance on the pure GA cases, in terms of
Dice coefﬁcient, was comparable with that on the BMES
and RS set (0.710.26 versus 0.720.26). However,
performance on mixed cases was signiﬁcantly worse, asB) square root GA area. Differences are calculated as the area or the square
andard deviation.
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Figure 3. Images showing examples of automatic geographic atrophy (GA) segmentation. The green area corresponds to either the (left) consensus or
(right) model output. The top 3 rows show accurate segmentation results for various conﬁgurations of GA differing in area, shape, and number of lesions and
variable image quality and contrast. The bottom row shows examples of inaccurate model output.
Ophthalmology Volume -, Number -, Month 2020was agreement between graders. Hence, these cases were
not included in the analysis of GA growth. We did not
observe any bias in the automatic assessment of GA area
or square root GA area.
The obtained mean square root annual growth rate on the
AREDS set (0.250.40 mm/year) was slightly lower than
previously reported values. For example, Domalpally et al31
observed 0.30 mm/year, and Keenan et al44 observed 0.28
mm/year. A reason for this may be the dependence ofTable 2. Square Root Annual Growth
Squa
All
Overall 0.250.40 (n ¼ 335)
Unifocal 0.220.39 (n ¼ 251)
Multifocal 0.330.43 (n ¼ 84)
P value 0.028
Foveal 0.210.41 (n ¼ 258)
Extrafoveal 0.360.36 (n ¼ 77)
P value 0.006
Unilateral 0.210.32 (n ¼ 41)
Bilateral 0.250.41 (n ¼ 128)
P value 0.58
Values represent meanstandard deviation. P values are calculated using an un
6growth rate on baseline area. When we split the dataset on
baseline lesion size, we observed that small lesions have
larger square root growth rates (Table 2). This
phenomenon was analyzed in more detail in Figure 5. A
quadratic curve seemed to ﬁt the observed GA progression
very well up to an area of approximately 12 mm2.
For larger areas, the growth rate seemed to stabilize
or even decrease, whereas the variability between
patients also increased. Similar observations were made byof the Geographic Atrophy Area
re Root Annual Growth (mm/year)
Small (<5 mm2) Large (5 mm2)
0.310.34 (n ¼ 194) 0.160.46 (n ¼ 141)
0.280.33 (n ¼ 142) 0.140.44 (n ¼ 109)
0.390.35 (n ¼ 52) 0.230.52 (n ¼ 32)
0.039 0.339
0.270.31 (n ¼ 120) 0.160.47 (n ¼ 138)
0.370.37 (n ¼ 74) 0.140.17 (n ¼ 3)
0.066 0.934
0.230.30 (n ¼ 29) 0.150.36 (n ¼ 12)
0.290.34 (n ¼ 72) 0.190.48 (n ¼ 56)
0.446 0.76
paired t test.
Table 3. Correlations between Baseline Lesion Characteristics (Features) and Square Root Annual Growth Rate (in Millimeters per Year)
Feature R2 Value Slope Intercept R Value P Value Standard Error
Area 0.101 e0.015 0.351 e0.318 < 0.001 0.002
Filled area 0.100 e0.015 0.351 e0.316 < 0.001 0.002
Convex area 0.081 e0.012 0.347 e0.285 < 0.001 0.002
Convex solidity 0.078 e0.743 0.849 e0.279 < 0.001 0.140
Eccentricity 0.073 0.647 e0.167 0.271 < 0.001 0.126
Roundness 0.073 e0.697 0.723 e0.270 < 0.001 0.136
Foveal involvement 0.050 e2.950 0.370 e0.225 < 0.001 0.701
Perimeter 0.029 e0.007 0.336 e0.170 0.002 0.002
Circularity 0.025 e0.282 0.384 e0.159 0.004 0.096
No. of lesions 0.024 0.078 0.130 0.154 0.005* 0.027
Filled solidity 0.001 0.646 e0.396 0.025 0.649* 1.419
Features are sorted in decreasing order of strength of association. A P value of less than 0.0045 (0.05, Bonferroni corrected) was considered signiﬁcant.
*Not signiﬁcant.
Figure 4. Graphs and images showing progression of geographic atrophy (GA) over time for 4 selected eyes. The graphs represent area measurements over
time (2 points per time point for the left and right stereoscopic images). The blue line is a quadratic ﬁt through the points. For the top 2 cases, an increment
in growth rate can be observed: 53834 left eye (LE) shows a more irregular shape than 51551 right eye (RE) and progressed faster. In the bottom 2 cases, we
observe that the growth decreased as the GA area increased.
Liefers et al  Deep Learning for Segmentation of GA
7
Table 4. Correlations between Baseline Lesion Characteristics (Features) and Square Root Annual Growth Rate (in Millimeters per Year)
for Baseline Lesion Size of Less than 12 mm2
Feature R2 Value Slope Intercept R Value P Value Standard Error
Convex solidity 0.076 e0.553 0.741 e0.276 < 0.001 0.117
Circularity 0.066 e0.365 0.486 e0.258 < 0.001 0.083
Roundness 0.060 e0.491 0.628 e0.245 < 0.001 0.118
Eccentricity 0.055 0.446 0.005 0.234 < 0.001 0.113
Foveal involvement 0.032 e1.858 0.368 e0.179 0.003 0.621
No. of lesions 0.031 0.076 0.188 0.175 0.004 0.026
Perimeter 0.007 0.005 0.252 0.086 0.156* 0.003
Area 0.001 e0.004 0.312 e0.034 0.574* 0.007
Filled area 0.001 e0.004 0.312 e0.034 0.580* 0.006
Convex area 0.001 0.002 0.289 0.026 0.671* 0.005
Filled solidity 0.000 0.091 0.209 0.004 0.948* 1.380
Features are sorted in decreasing order of strength of association. A P value of less than 0.0045 (0.05, Bonferroni corrected) was considered signiﬁcant.
*Not signiﬁcant.
Ophthalmology Volume -, Number -, Month 2020Keenan et al,44 whose reported values are included in
Figure 5 for comparison.
The importance of baseline area for assessing growth
rate also became apparent in the regression analysis,
where area, ﬁlled area, and convex area were correlated
most strongly with square root annual growth rate.
However, when we included only lesions with baseline
area of less than 12 mm2 in the regression analysis, no
features related to lesion size were signiﬁcantly associated
with square root annual growth rate (Table 4). On an
individual level, we also observed a quadratic growth of
the area of GA in many cases in the AREDS set, some
of them highlighted in Figure 4, in which we ﬁtted a
quadratic curve through the GA area over time. Again,
the decrease in growth rate for larger lesions was
visible (bottom 2 cases in Fig 4).Figure 5. Graphs showing geographic atrophy (GA) growth over time. A, Geogra
area. The blue line represents growth rates estimated from the segmentations of
interval (estimated using bootstrapping). The dashed red line represents the grow
evolution of GA area over time, obtained by numerically integrating the estimated
line represents the best quadratic ﬁt to the plot for GA area of less than 12 mm
8Of the features that are invariant to lesion size, convex
solidity was associated most signiﬁcantly with square root
annual growth rate. Convex solidity is low for irregularly
shaped lesions but also for multifocal lesions. Hence, this
feature captures multiple previously reported associations.
Of note, the association of square root annual growth rate
with circularity was much stronger in the subset of images
with baseline area of less than 12 mm2. We observed that
the average value for circularity of large lesions (12 mm2)
was signiﬁcantly lower: 0.400.19 versus 0.510.23 for
small lesions (P < 0.001). For large lesions in particular, the
model may have produced a segmentation with a very jag-
ged border for lesions with indistinct borders of the atrophic
area. This could have led to a relatively large perimeter and
hence a lower value for circularity. In those cases, roundness
will be a better representation of how well the lesionphic atrophy growth rate (in square millimeters per year) as a function of GA
the deep learning model. The shaded area represents the 95% conﬁdence
th rate of a quadratic model, as visualized in (B). B, Blue line represents the
growth rates from (A) using a GA area of 0.5 mm2 at t ¼ 0. The red dashed
2. Above this area, the observed GA area diverges from the quadratic ﬁt.
Table 5. Dice Coefﬁcients on the 50 Images Selected from the
Age-Related Eye Disease Study Dataset for the Model and 2
Graders Compared with the Reference Grader
All (n [ 50)
Pure Geographic
Atrophy (n [ 30) Mix (n [ 20)
Model 0.660.27 0.710.26 0.590.27
Grader 2 0.730.24 0.780.22 0.640.25
Grader 3 0.730.27 0.810.21 0.610.31
Liefers et al  Deep Learning for Segmentation of GAapproaches a circular shape, because it represents the ratio
of the area of an enclosing circle and the area of the lesion
and hence is less sensitive to irregular borders.45 Indeed,
contrary to circularity, roundness was signiﬁcantly higher
for large lesions (12 mm2): 0.760.10 versus 0.670.16
for small lesions (P < 0.001).
The multivariate model, which included 6 features related
to the baseline shape and size of the GA area, was able to
explain 18% of the variation in square root annual growth
rate. It is unclear how much of the actual variation is
explainable, because there may be factors inﬂuencing the
growth rate that are not expressed in the image, such as ge-
netics,46 and possibly lifestyle or environmental factors.
Moreover, inclusion of follow-up information or lesion pat-
terns around the border of the GA area may improve the
model further, because those have been previously demon-
strated to contain additional information and are not captured
by the presented multivariate model.12 The model also does
not take into account nonlinear interactions between
features. Finally, errors in the automatically segmented GA
may have resulted in inaccuracies, both in the estimation of
the features and in the estimation of square root annual
growth rate. Therefore, it is to be expected that in future
work, building a model that captures more of the observed
variation in growth rate will be achievable.
A limitation of our study is that the conversion from
pixels to millimeters may have been inaccurate. This con-
version was based on the average distance between fovea
and optic disc in a subset of images. Although it is unlikely
that this inaccuracy was a source for bias in reported asso-
ciations with growth rate, reported values for area and
growth rate may be slightly larger or smaller in reality.
Furthermore, direct application of the model in a setting
where small errors are detrimental, such as clinical trials
with GA area or progression rates as the end point, is
currently beyond reach. The model may still fail in some
cases, and additionally, color fundus imaging may not be the
main method for assessment of GA in such a setting, where
OCT and FAF are preferred. Nevertheless, the output of the
model could still be valuable as a secondary measurement
for identiﬁcation of cases that may need further
adjudication.13,26
In the future, we will extend the model to other methods,
speciﬁcally FAF and OCT. This may give more accurate
measurements of the atrophic area and hence more reliable
assessment of growth rate. In this study, only morphologic
features of the atrophic area were considered. A next step
would be to include associations between growth rate and
other lesions patterns, especially those visible on FAF orOCT. Finally, we are investigating the capabilities of deep
learning models to predict directly areas where GA may
develop. This will provide predictions of both the extent and
location of future GA area.
In conclusion, we have presented and validated a robust
segmentation model based on deep learning for GA on
CFIs. The model was capable of reproducing known asso-
ciations between current GA status and future growth.
Moreover, we indicated novel structural biomarkers that are
predictive for future growth rate, such as solidity, eccen-
tricity, or roundness of the lesion. We demonstrated how
deep learning can help in the automation of grading,
allowing for analysis of larger datasets and helping to un-
derstand progression of GA.
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